CBD Extraction Process Patent Pending THC Free Product Line

Medical Marijuana Inc. (Pinksheets:MJNA - News) and CannaBANK™, in association with SkinAgain® (www.skinagain.com), a Carlsbad, CA-based cosmeceutical firm, are proud to announce a patent filed for extracting cannabinoids (CBD) from cannabis.

Recognizing the potential healthcare benefits of cannabinoids, the United States government successfully filed a patent for CBDs as antioxidants and neuroprotectants that was granted on October 7, 2003 (see http://tinyurl.com/6hwwmt). Cannabidiol, the most specific non-psycho active, beneficial compound had originally been listed in the Federal Register (7372) as a Schedule 1 drug or substance but was notably absent from the list in a Code of Federal Regulations change since April 1, 2010. Some of the benefits stated in the government's patent brief included cannabinoids having antioxidant properties and being useful in treating autoimmune disorders, stroke, Alzheimer's disease, Parkinson's disease and HIV.

CannaBANK™ and SkinAgain® researchers, while undergoing a thorough 'landscape' patent search and discovering that CBDs were removed from the Schedule I list, designed a specific process that would not only extract CBDs, but also remove the Tetrahydrocannabinols (THC) from cannabis, which would result in a form enabling end users to receive the full efficacy of the CBDs without experiencing any of the psychoactive effects caused by THC. The THC-free cannabinoid material will be formulated into capsules, tablets, and topicals. CannaBank expects to release the first CBD-infused products into the marketplace over the next several months.